[1]
2023. The use of SGLT2 to improve clinical outcome in patients with heart failure and chronic kidney disease: a systematic review. Electronic Journal Collection Health. 23, 2 (Feb. 2023), e11571. DOI:https://doi.org/10.25248/reas.e11571.2023.